🇭🇰 International Pharmaceutical Sourcing · Hong Kong
Access Oncology & Specialty Medicines
in Hong Kong
Hong Kong maintains one of Asia's most sophisticated healthcare environments, yet patients managing cancer, blood disorders, HIV, hepatitis, and other complex conditions may find that certain specialty medicines are not yet registered with the Department of Health, are pending local formulary listing, or require access through personal importation pathways.
Medsmonk is an international pharmaceutical sourcing platform supporting patients in Hong Kong with access to prescription specialty medicines from verified global suppliers. Every order is prescription-based, comprehensively documented, and managed with rigorous compliance at every stage of the process. We operate alongside patients' treating physicians — we do not prescribe, diagnose, or provide medical advice of any kind.
01
Oncology & Specialty Medicines We Support in Hong Kong
Oncology
Medicines not yet registered with the Hong Kong Department of Health or facing limited availability through standard oncology supply channels in Hong Kong.
Oncology
EGFR, ALK, KRAS, BRAF and other precision oncology agents where local registration is pending or access through standard Hong Kong channels presents clinical challenges.
Oncology
PD-1, PD-L1 and CTLA-4 checkpoint inhibitors — including newer agents where Department of Health registration or formulary access may present barriers.
Oncology
Ultra-rare disease treatments and enzyme replacement therapies with no current local registration or very limited authorised supply in Hong Kong.
Oncology
Medicines managing treatment side effects, maintaining patient function, and improving tolerability during active cancer treatment programmes.
Hematology
AML, CML, CLL and ALL medicines including BCR-ABL inhibitors, targeted kinase inhibitors, and newer small molecule therapies for blood cancers.
Hematology
Treatments for Hodgkin's, non-Hodgkin's lymphoma, and multiple myeloma including proteasome inhibitors and targeted monoclonal antibodies.
Hematology
Thrombopoietin receptor agonists and medicines for immune thrombocytopenia (ITP) and related platelet disorder conditions.
Hematology
Erythropoiesis-stimulating agents and immunosuppressive therapies for aplastic anaemia and blood production disorders.
Hematology
Factor replacement therapies and specialty medicines for haemophilia, clotting disorders, and anticoagulation management under valid prescription.
Women's Health
Treatments for endometriosis, PCOS, menopausal hormone therapy, and other hormone-dependent conditions requiring specialist prescription access.
Women's Health
CDK4/6 inhibitors, aromatase inhibitors, PARP inhibitors, and HER2-targeted agents — including medicines pending local formulary listing in Hong Kong.
Women's Health
Medicines for ovarian, cervical, and uterine cancers including PARP inhibitors, ADC therapies, and targeted biologics not yet locally listed.
Women's Health
Fertility-related and reproductive support medicines where specialist prescription access or supply consistency may present challenges in Hong Kong.
Men's Health
Abiraterone acetate, enzalutamide, darolutamide, and androgen-pathway therapies for advanced prostate cancer including newer generation agents.
Men's Health
Hormone replacement and androgen suppression therapies for male-specific endocrine conditions and hormone-related cancers requiring specialist prescription.
Men's Health
Specialty medicines for testicular cancers, BPH, and male urological conditions supplied under valid prescription and appropriate clinical documentation.
Men's Health
Prescription erectile dysfunction medicines where specialist access or supply continuity may present considerations for patients in Hong Kong.
HIV
First-, second-, and third-line ART including newer integrase strand transfer inhibitors and single-tablet combination regimens for patients in Hong Kong.
HIV
PrEP medicines for HIV prevention. Valid prescription required. All PrEP orders handled with complete professional confidentiality and discreet packaging.
HIV
Medicines managing opportunistic infections, HIV-associated malignancies, and comorbid conditions in people living with HIV in Hong Kong.
Hepatitis
Entecavir, tenofovir alafenamide (TAF), and other antiviral agents for chronic Hepatitis B management and long-term liver protection.
Hepatitis
Pan-genotypic DAA regimens including sofosbuvir/velpatasvir and glecaprevir/pibrentasvir combinations for Hepatitis C treatment.
Hepatitis
Supportive medicines for cirrhosis, liver fibrosis management, and hepatic complications arising from chronic viral hepatitis infection.
02
How to Order from Hong Kong
1
Submit Prescription & Clinical Documents
Provide a valid prescription from a registered medical practitioner in Hong Kong, together with relevant diagnostic reports, specialist referrals, or clinical documentation supporting your medicine requirement. All prescription medicines require valid documentation before any order is processed, without exception.
2
Receive a Detailed Written Quotation
Our sourcing team reviews your request and provides a clear, itemised written quotation covering medicine, dosage, quantity, and estimated international shipping. You are under no obligation to proceed upon receiving a quotation.
3
Confirm Your Order
Upon accepting the quotation, your order is formally confirmed and our procurement team initiates sourcing from verified international manufacturers or authorised distributors only.
4
International Dispatch & Export Documentation
Medicines are packed to pharmaceutical standards with validated cold-chain provisions where required. Complete export documentation is prepared to support Hong Kong Customs and Excise and Department of Health clearance requirements where applicable.
5
Tracking & Delivery Support
Full shipment tracking information is provided upon dispatch. Our team remains available to assist with any Hong Kong Customs or Department of Health documentation queries throughout the delivery process.
03
Prescription & Regulatory Notice — Hong Kong
📋
All prescription medicines require a valid prescription from a registered medical practitioner in Hong Kong. Medsmonk will not supply any prescription medicine without appropriate clinical documentation, without exception.
🏛️
The importation of pharmaceutical products into Hong Kong is regulated under the Pharmacy and Poisons Ordinance (Cap. 138). Patients are responsible for familiarising themselves with applicable Department of Health import conditions before placing an order.
🚫
Dangerous drugs and certain controlled medicines are regulated under the Dangerous Drugs Ordinance (Cap. 134). Import licences from the Department of Health are required for such substances. Patients must not attempt to import controlled substances without securing the required authorisation in advance.
📦
Importation must be for personal therapeutic use only and in quantities consistent with the individual patient's treatment needs. Quantities exceeding personal use thresholds may be subject to additional review by Hong Kong Customs and Excise or the Department of Health.
⚖️
Patients are fully responsible for ensuring compliance with all applicable Hong Kong import regulations, Customs and Excise requirements, and Department of Health guidelines relevant to their specific medicine. Medsmonk provides supporting documentation but regulatory compliance responsibility remains entirely with the patient.
⚠️ Important Notice: Medsmonk does not provide legal, customs, or regulatory advice. All patients in Hong Kong are strongly encouraged to consult their treating physician and seek specific guidance from the Hong Kong Department of Health before initiating any international medicine importation. Medsmonk does not replace the advice of registered Hong Kong medical practitioners.
04
Delivery & Handling Standards — Hong Kong
📍 Areas We Serve
⏱️ Estimated Shipping Window
3–5
Business Days
Indicative estimate only. Subject to Hong Kong Customs and Excise processing, Department of Health clearance requirements where applicable, carrier routing, and country of origin. We do not guarantee specific delivery dates. Plan medicine supply well in advance of your anticipated requirement.
05
Why Choose Medsmonk for Hong Kong
Hong Kong Access Experience
Familiar with Hong Kong's Pharmacy and Poisons Ordinance framework, Department of Health registration status, and the specialty access challenges faced by patients.
Transparent & Documented
Every order includes a clear written quotation and full manufacturer documentation. No hidden fees, no undisclosed charges — ever.
Quality-Assured Sourcing
Sourced exclusively from licensed manufacturers and authorised distributors. Authenticity documentation, batch records, and quality certificates with every supply.
Cold-Chain Handling
Temperature-sensitive medicines are handled with validated cold-chain packaging throughout international transit to maintain full pharmaceutical integrity on arrival.
Hard-to-Access Medicines
Specialising in oncology, hematology, HIV, and rare disease medicines with limited Department of Health registration or restricted local formulary availability.
Confidential & Professional
HIV medicines and other sensitive categories are handled with complete professional discretion. Shipments use discreet outer packaging with no identifying medical information on the exterior.
06
Popular Medicines
Lorlatinib Tablets
Osimertinib 80 mg
Regorafenib Tablets
Abiraterone Acetate
Enzalutamide Capsules
Palbociclib Capsules
Olaparib Tablets
Venetoclax Tablets
Ibrutinib Capsules
Ruxolitinib Tablets
Eltrombopag Tablets
Pembrolizumab Injection
Trastuzumab Injection
Sofosbuvir / Velpatasvir
Tenofovir Alafenamide
Biktarvy (B/F/TAF)
Descovy (PrEP)
Lenvatinib Capsules
Cabozantinib Tablets
Darolutamide Tablets
All medicines require a valid prescription from a registered medical practitioner in Hong Kong. Please consult your specialist to confirm suitability for your individual treatment plan. This list is provided for informational purposes only and does not constitute a medical recommendation or solicitation.
07
Frequently Asked Questions — Hong Kong
Personal importation of prescription medicines into Hong Kong is regulated under the Pharmacy and Poisons Ordinance (Cap. 138). Patients may import medicines for personal use with a valid prescription, subject to applicable conditions. Certain medicine categories require an import licence from the Department of Health. Dangerous drugs are subject to additional controls under the Dangerous Drugs Ordinance (Cap. 134). We strongly recommend consulting your physician and the Department of Health before initiating any importation.
Yes, without exception. A valid prescription from a registered medical practitioner is required for all orders placed by patients in Hong Kong. Medsmonk does not supply prescription medicines without appropriate clinical documentation, regardless of medicine category or urgency. We do not prescribe medicines or substitute for professional medical consultation.
Estimated delivery timelines generally range from 7 to 15 business days from dispatch, subject to Hong Kong Customs and Excise processing, Department of Health clearance for specific medicine categories, and international carrier routing. We do not guarantee specific delivery dates and strongly recommend planning orders well in advance.
Yes. Oncology medicines Hong Kong is one of Medsmonk's core areas of focus. We support access to chemotherapy agents, targeted therapies, immunotherapy, hematology medicines, and rare cancer treatments for patients in Hong Kong — subject to valid prescription and applicable Department of Health import regulations. Medicines not yet locally registered may be accessible through personal importation with appropriate clinical and regulatory documentation.
Yes. Medsmonk supports access to antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) for patients in Hong Kong. All HIV medicines require a valid prescription from a registered medical practitioner. Every HIV medicine order is handled with complete professional confidentiality — shipments use discreet outer packaging with no identifying medical information on the exterior of the parcel.
Yes. Medsmonk supports access to Hepatitis B antivirals — including entecavir and tenofovir alafenamide — and Hepatitis C direct-acting antivirals (DAAs), including pan-genotypic regimens such as sofosbuvir/velpatasvir, for patients in Hong Kong. All hepatitis treatments require a valid prescription, and quality and authenticity documentation accompanies every supply.
Yes. All medicines are sourced exclusively from licensed manufacturers and authorised distributors. Authenticity documentation, batch records, and quality certificates accompany every supply to Hong Kong. Medsmonk does not engage with grey-market suppliers, unverified intermediaries, or any source that cannot provide full manufacturer-level documentation and quality assurance.
Temperature-sensitive medicines — including certain biologics, monoclonal antibodies, and injectables — are handled with validated cold-chain packaging and logistics throughout the entire international shipping process. We use insulated packaging and appropriate cooling materials to maintain pharmaceutical integrity during transit to Hong Kong. Storage and handling guidance upon receipt is provided at the quotation stage where applicable.